The taxes are part of the president's push to rein in the pharmaceutical industry and bring manufacturing to the U.S.
The White House is asking Congress to cut $5 billion from the National Institutes of Health and downsize the number of ...
Congress largely ignored President Trump's previous budget proposal, instead boosting federal health spending.
The volume of evidence behind a therapy has become inversely correlated with public trust in it,” writes Vikas Patel.
A quiet effort to change the name of PCOS is nearing completion, driven in part by growing evidence of a male version.
The CDC has “temporarily paused” diagnostic testing for rabies and pox viruses, according to a recent update to the agency ...
Eli Lilly’s obesity pill was approved by the FDA, setting it up for fierce competition against Novo Nordisk’s new Wegovy pill ...
The move came after months of talks in which Doctors Without Borders asked Gilead Sciences for a “limited” supply of ...
One is a Cochrane review, published in January, that examined the literature on THC efficacy in treating chronic pain — ...
The FDA yesterday approved Eli Lilly’s weight loss pill, orforglipron. The agency is also facing renewed scrutiny over ...
The Trump administration is changing the name of the federal health IT office back to the Office of the National Coordinator.
The Trump administration is negotiating new drug-pricing deals, now with smaller companies, according to three people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results